Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis

被引:17
|
作者
Walsh, NM
Casano, AA
Manangan, LP
Sinkowitz-Cochran, RL
Jarvis, WR
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Healthcare Qual Promot, Atlanta, GA 30333 USA
[2] Dept Hlth & Human Serv, Atlanta, GA USA
来源
JOURNAL OF PEDIATRICS | 2002年 / 141卷 / 04期
关键词
D O I
10.1067/mpd.2002.127665
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: To determine risk factors for acquiring Burkbolderia cepacia complex among patients with cystic fibrosis (CF). Study design: A case-control study v was conducted with active surveillance for B cepacia complex colonization/infection among patients at 21 CF centers from April 1986 to March 1989 (study, period). A case-patient was defined as any CF patient with B cepacia complex colonization for the first time during the study period. Control patients were patients with CF not B cepacia complex colonized during the study period. For each patient, a questionnaire was completed semiannually. Results: In multivariate analyses, hospitalization for pulmonary exacerbations, living with a B cepacia complex-positive person, attending a CF summer camp, and direct contact with a B cepacia complex-colonized CF person outside of camp and home were associated with B cepacia complex acquisition. Receiving antimicrobial aerosol therapy or cleaning and drying a home-used nebulizer between uses, were associated with a decrease in B cepacia complex acquisition, Conclusions: Numerous factors inside and outside the health care setting are associated with person-to-person transmission of B cepacia complex among patients with CF. Prevention programs should reduce direct or indirect contact between noncolonized and B cepacia z complex-colonized/infected patients with CF.
引用
收藏
页码:512 / 517
页数:6
相关论文
共 50 条
  • [21] Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia
    Ledson, MJ
    Gallagher, MJ
    Corkill, JE
    Hart, CA
    Walshaw, MJ
    THORAX, 1998, 53 (05) : 432 - 436
  • [22] Burkholderia cepacia complex infection in Italian patients with cystic fibrosis:: Prevalence, epidemiology, and genomovar status
    Agodi, A
    Mahenthiralingam, E
    Barchitta, M
    Gianninò, V
    Sciacca, A
    Stefani, S
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) : 2891 - 2896
  • [23] Burkholderia cepacia complex infection in patients with cystic fibrosis:: laboratory investigations, epidemiology and clinical management
    Ryley, HC
    Doull, IJM
    REVIEWS IN MEDICAL MICROBIOLOGY, 2003, 14 (01) : 15 - 24
  • [24] Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients
    Kenna, Dervla T. D.
    Lilley, Daniel
    Coward, Amy
    Martin, Kate
    Perry, Claire
    Pike, Rachel
    Hill, Robert
    Turton, Jane F.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (04) : 490 - 501
  • [25] Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis
    Frost, Freddy
    Shaw, Matthew
    Nazareth, Dilip
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (06):
  • [26] Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis
    Frost, Freddy
    Shaw, Matthew
    Nazareth, Dilip
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (12):
  • [27] Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis
    Lekkas, Anastasios
    Gyi, Khin M.
    Hodson, Margaret E.
    JOURNAL OF CYSTIC FIBROSIS, 2006, 5 (02) : 121 - 124
  • [28] Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients
    Coenye, T
    LiPuma, JJ
    Henry, D
    Hoste, B
    Vandemeulebroecke, K
    Gillis, M
    Speert, DP
    Vandamme, P
    INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2001, 51 : 271 - 279
  • [29] Burkholderia cepacia in cystic fibrosis
    Wilmott, RW
    JOURNAL OF PEDIATRICS, 2002, 141 (04): : 3A - 3A
  • [30] Risk factors for Burkholderia cepacia complex Bacteremia among intensive care unit patients without cystic fibrosis:: A case-control study
    Bressler, Adam M.
    Kaye, Keith S.
    LiPuma, John J.
    Alexander, Barbara D.
    Moore, Christopher M.
    Reller, L. Barth
    Woods, Christopher W.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (08): : 951 - 958